- CORRESPONDENCE
Drug woes won’t be tamed by US price regulations
Nature 648, 278 (2025)
doi: https://doi.org/10.1038/d41586-025-03999-1
Competing Interests
R.X. is a Senior Health Economist at RA Capital Management, which invests in public and private health-care and life-sciences companies developing drugs, medical devices, diagnostics, services and research tools.
The TrumpRx website won’t slash drug prices — but this will
Pharmaceutical giants pull out of UK: why it matters for global science